Prevention of Vascular Injury by Combination of an AT1 Receptor Blocker, Olmesartan, With Various Calcium Antagonists

Shinji Inaba(Ehime University), Masatsugu Horiuchi(Ehime University), Megumi Furuno(Ehime University), Izumi Senba(Ehime University), Hideki Okayama(Ehime Prefectural Central Hospital), Yumiko Tomono(Ehime University), Harumi Kan‐no(Ehime University), Masaru Iwai(Yamagata University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Masaki Mogi(Ehime University)
American Journal of Hypertension
December 4, 2008
10.1038/ajh.2008.344
Cited by 25

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy
|Hypertension Research|2024|341